| abstract |
A method for treating malignant tumors in human patients, comprising administering trans-3-amino-1-methyl-3-(4-(3-phenyl- 5H-imidazo[1,2-c]pyrido[3,4-e][1,3] -2-yl)phenyl)cyclobutanol) (compound 1) or its salt, and the administration schedule includes: the aforementioned compound 1 or its salt, based on the amount of compound 1, use 4mg/body/day~160mg /Body/Daily dose for 4 consecutive days after the prescribed withdrawal period of 3 days. |